Amy Simon - Net Worth and Insider Trading

Amy Simon Net Worth

The estimated net worth of Amy Simon is at least $2 Million dollars as of 2024-10-05. Amy Simon is the Chief Medical Officer of Beam Therapeutics Inc and owns about 68,805 shares of Beam Therapeutics Inc (BEAM) stock worth over $2 Million. Details can be seen in Amy Simon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Simon has not made any transactions after 2024-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Amy Simon

To

Amy Simon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy Simon owns 1 companies in total, including Beam Therapeutics Inc (BEAM) .

Click here to see the complete history of Amy Simon’s form 4 insider trades.

Insider Ownership Summary of Amy Simon

Ticker Comapny Transaction Date Type of Owner
BEAM Beam Therapeutics Inc 2024-07-02 Chief Medical Officer

Amy Simon Latest Holdings Summary

Amy Simon currently owns a total of 1 stock. Amy Simon owns 68,805 shares of Beam Therapeutics Inc (BEAM) as of July 2, 2024, with a value of $2 Million.

Latest Holdings of Amy Simon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BEAM Beam Therapeutics Inc 2024-07-02 68,805 23.41 1,610,725

Holding Weightings of Amy Simon


Amy Simon Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy Simon has made a total of 5 transactions in Beam Therapeutics Inc (BEAM) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Beam Therapeutics Inc is the sale of 1,250 shares on July 2, 2024, which brought Amy Simon around $29,100.

Insider Trading History of Amy Simon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy Simon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Amy Simon Ownership Network

Ownership Network List of Amy Simon

No Data

Ownership Network Relation of Amy Simon

Insider Network Chart

Amy Simon Owned Company Details

What does Beam Therapeutics Inc do?

Who are the key executives at Beam Therapeutics Inc?

Amy Simon is the Chief Medical Officer of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include Chief Legal Officer Christine Bellon , director & CEO John M. Evans , and President & CSO Giuseppe Ciaramella .

Beam Therapeutics Inc (BEAM) Insider Trades Summary

Over the past 18 months, Amy Simon made 4 insider transaction in Beam Therapeutics Inc (BEAM) with a net sale of 28,776. Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 198,102 shares made by John M. Evans , and a net sale of 161,064 shares made by Giuseppe Ciaramella .

In summary, during the past 3 months, insiders sold 60,674 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 60,674 shares. During the past 18 months, 1,311,323 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,311,323 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Beam Therapeutics Inc Insider Transactions

No Available Data

Amy Simon Mailing Address

Above is the net worth, insider trading, and ownership report for Amy Simon. You might contact Amy Simon via mailing address: Beam Therapeutics, Inc., 238 Main Street, 9th Fl., Cambridge Ma 02142.

Discussions on Amy Simon

No discussions yet.